Summary & Overview
CPT 0714T: Transperineal Laser Ablation of Benign Prostatic Tissue
CPT code 0714T represents transperineal laser ablation of benign prostatic tissue for enlarged prostate when prostate volume is under 50 mL. The code bundles imaging guidance with the ablation procedure. Nationally, this code is relevant as minimally invasive prostate procedures expand treatment options for lower urinary tract symptoms due to benign prostatic hyperplasia, with implications for ambulatory surgical utilization and payer coverage policies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical service and typical sites of service, payer coverage landscape, common billing modifiers, and where 0714T sits among related procedural options. The publication summarizes benchmark considerations, coding nuances for transperineal approach and prostate size limitation, and policy developments that may affect claims processing and prior authorization practices.
This summary is intended to orient clinicians, coding professionals, and policy analysts to the primary clinical intent of the code, which patients it applies to, and the billing context stakeholders should consider when managing or reviewing claims for transperineal laser ablation.
Billing Code Overview
CPT code 0714T describes a laser ablation of benign prostatic tissue for an enlarged prostate using a transperineal approach (through the tissue between the scrotum and anus). The procedure includes imaging guidance and specifically applies when the prostate volume is less than 50 mL.
Service Type: Minimally invasive surgical procedure; prostate tissue ablation
Typical Site of Service: Ambulatory surgery center or hospital outpatient department; may also be performed in specialized urology procedural suites
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 65-year-old male with symptomatic benign prostatic hyperplasia (BPH) causing urinary frequency, nocturia, weak stream, and incomplete emptying who has failed or is intolerant to medical therapy. Prostate volume is confirmed by ultrasound or MRI and is less than 50 mL, making the patient a candidate for transperineal laser ablation. The procedure is performed in an ambulatory surgical center or hospital outpatient department under monitored anesthesia care or general anesthesia. The provider positions the patient in lithotomy, prepares the perineal skin, and uses ultrasound or fluoroscopic imaging guidance to target intraprostatic tissue through a transperineal approach. Laser energy is applied to ablate obstructive periurethral prostatic tissue while real-time imaging confirms needle/laser fiber placement and extent of ablation. Post-procedure monitoring includes urinary catheter management, pain control, and short observation for bleeding or urinary retention prior to discharge. Typical documentation includes prostate volume, imaging modality used, estimated ablation time/energy, intraoperative findings, anesthesia type, postoperative catheter status, and any complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical (document justification and additional work). |